12:00 AM
Mar 19, 2012
 |  BC Week In Review  |  Company News  |  Deals

Immunovaccine, Weill Cornell Medical College deal

Immunovaccine and the college partnered to evaluate Cornell's preclinical vaccine to treat cocaine addiction with Immunovaccine's DepoVax delivery system. The...

Read the full 90 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >